CYC 682 Translating cancer biology into medicines NASDAQ CYCC September 2019 Disclaimer | --- | --- | |--------------------------------------------------------------------------------------|---------------| | | | | This presentation contains forward-looking statements | within the | | meaning of the "safe harbor" provisions of the Private | Securities | | Litigation Reform Act of 1995 about financial results and | estimates, | | business strategy, clinical trial plans and research and | development | | prog ...